Natdac 60 Daclatasvir Dihydrochloride 60 Mg

Natdac 60 Daclatasvir Dihydrochloride 60 Mg

Product Details:

  • Indication Treatment of Chronic Hepatitis C Virus (HCV) infection
  • Assay Not less than 98.0% and not more than 102.0%
  • Origin of Medicine India
  • Expiration Date 2 years from the date of manufacture
  • CAS No 1009119-65-6
  • Appearance Yellow biconvex film-coated tablet
  • Molecular Formula C40H52N8O6
  • Click to view more
X

Natdac 60 Daclatasvir Dihydrochloride 60 Mg Product Specifications

  • Yellow biconvex film-coated tablet
  • 1009119-65-6
  • 2 years from the date of manufacture
  • India
  • Treatment of Chronic Hepatitis C Virus (HCV) infection
  • Not less than 98.0% and not more than 102.0%
  • Oral administration as prescribed by a healthcare provider
  • Store below 30°C in a dry place protected from light
  • 28 tablets per box
  • C40H52N8O6
  • Pharmaceutical Grade
  • Allopathic
  • Daclatasvir Dihydrochloride
  • Tablet
  • 60 mg per tablet

Other Products in 'Anti Infective Medicine' category



Get in touch with us
RFQ Request For Quotation
Get Quotes For Your Buying Requirement. Tell Suppliers What You Need.
I agree to abide by all the Terms and Conditions of tradeindia.com